Multi - Factor Authentication (MFA)
Search documents
CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th
Globenewswire· 2025-12-05 21:55
SARASOTA, Fla., Dec. 05, 2025 (GLOBE NEWSWIRE) -- CyberloQ Technologies, Inc (OTCQB:CLOQ) based in Sarasota, FL., focused on cybersecurity, today announced that Chris Jackson, Company President will present live at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com, on December 9th. DATE: December 9th TIME: 3:00 PM Eastern Standard TimeLINK: REGISTER HEREAvailable for 1x1 meetings: December 10th, 11th, between 9am-1pm Eastern Standard Time. Schedule 1x1 Meetings here T ...
BIO-key Q2’25 Revenue Rose 49% Driven by Increases Across All Three Segments; Launches “BIO-key CyberDefense Initiative” to Support Growing Global Investment in Military and Defense Preparedness; Investor Call 10am ET Today
Globenewswire· 2025-08-13 12:30
Core Insights - BIO-key International, Inc. reported a 49% increase in Q2'25 revenues to $1.7 million compared to $1.1 million in Q2'24, driven by higher sales across its business segments [9][10] - The company is focusing on expanding its Identity and Access Management (IAM) solutions in the global defense market through the BIO-key CyberDefense Initiative, capitalizing on increased European defense spending [4][5] - The gross margin for Q2'25 was 73%, down from 77% in Q2'24, attributed to a rise in hardware sales, which typically have lower margins [7][11] Financial Performance - Q2'25 software license fees increased by 4% to $806,087, while services revenues rose to $321,996, and hardware sales surged to $568,824 from $83,492 in Q2'24 [9][10] - Total operating expenses decreased by 8.5% to $2.3 million, with a 13.5% reduction in selling, general, and administrative expenses [12] - The net loss for Q2'25 improved to $1.2 million, or $0.20 per share, compared to a net loss of $1.7 million, or $1.00 per share, in Q2'24 [13] Market Strategy - The company is refocusing its sales efforts on BIO-key branded solutions in EMEA and domestic markets, enhancing its market presence [3] - The BIO-key CyberDefense Initiative aims to establish partnerships with defense industry prime contractors, leveraging the growing demand for cybersecurity solutions [4][5] - BIO-key anticipates significant contract activity in the first half of next year, supported by a robust pipeline of opportunities [6] Balance Sheet and Cash Flow - As of June 30, 2025, total current assets were $4.0 million, including $2.3 million in cash and cash equivalents, compared to $1.9 million at the end of 2024 [14][22] - The company reduced its note payable by $0.4 million in Q2'25, leaving a balance of $0.3 million [14] - The net cash provided from financing activities in the first half of 2025 was $3.5 million, contributing to an increase in cash and cash equivalents to $2.3 million [26]